Voyageur Non Current Assets Total from 2010 to 2024
| VM Stock | CAD 0.07 0.01 8.33% |
Non Current Assets Total | First Reported 2015-11-30 | Previous Quarter 2.1 M | Current Value 2.1 M | Quarterly Volatility 649.4 K |
Check Voyageur Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Voyageur Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 703.5 K, Other Operating Expenses of 779.8 K or Total Operating Expenses of 779.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.14. Voyageur financial statements analysis is a perfect complement when working with Voyageur Pharmaceuticals Valuation or Volatility modules.
Voyageur | Non Current Assets Total |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.